Clay Smith, MD, is a highly accomplished medical professional with extensive experience in hematology and oncology. Currently serving as Chief Scientific Officer at OncoVerity since May 2022, Clay Smith is a co-founder focused on translational research for pipeline development. Additionally, Clay Smith holds the position of Chief Innovation Officer at RefinedScience, contributing to project development and integration of clinical and bioinformatics with medicine. Previously, Clay Smith was a Professor at the University of Colorado Anschutz from May 2012 to April 2024, where responsibilities included directing multiple hematologic programs and advancing precision medicine initiatives. Additional leadership roles included serving as Director of the Hematologic Malignancies Program at UPMC and the Leukemia/BMT Program at BC Cancer Agency. Clay Smith earned an MD from UT Southwestern Medical Center and a BA in Biochemistry and Molecular Biology from Rice University.
This person is not in any teams
This person is not in any offices